12:00 AM
 | 
Feb 14, 2011
 |  BC Week In Review  |  Company News  |  Other News

Antisoma cancer news

Antisoma will reduce headcount by about 40-50 to about 10 by March 31 as part of its previously announced restructuring to save cash. Antisoma announced plans to immediately restructure last month after discontinuing development of acute myelogenous leukemia (AML) candidate...

Read the full 180 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >